FibroCell-001

N/A

Report date: 2025/10/27 20:00:53

Base Information

Drug NameFibroCell-001
Drug Alias Name异体人成纤维细胞FibroCell-001
ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Somatic cell > Fibroblast therapy
Mechanisms of ActionCell replacements
TargetsUpdating
Therapy Area/IndicationsIntervertebral Disc Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesZhiyuan Medical Technology (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhiyuan Medical Technology (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsIntervertebral Disc Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A